Augusto Amici Selected Research

Proteasome Inhibitors

1/2017

Resveratrol fuels HER2 and ERα-positive breast cancer behaving as proteasome inhibitor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Augusto Amici Research Topics

Disease

39	Neoplasms (Cancer) 01/2022 - 02/2002
24	Breast Neoplasms (Breast Cancer) 01/2022 - 03/2005
12	Carcinogenesis 11/2020 - 02/2002
11	Carcinoma (Carcinomatosis) 01/2019 - 04/2003
2	Triple Negative Breast Neoplasms 01/2021 - 01/2016
2	Adenocarcinoma 04/2011 - 05/2004
1	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2020
1	Rhabdomyosarcoma 04/2019
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2016
1	Obesity 11/2015
1	Infections 10/2013
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 10/2013

Drug/Important Bio-Agent (IBA)

13	DNA VaccinesIBA 01/2021 - 04/2004
13	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2003
12	DNA (Deoxyribonucleic Acid)IBA 08/2021 - 05/2003
5	VaccinesIBA 01/2021 - 03/2006
4	AntigensIBA 01/2021 - 01/2010
4	Biological ProductsIBA 12/2019 - 02/2007
4	AntibodiesIBA 04/2019 - 02/2002
4	Protein Isoforms (Isoforms)IBA 12/2018 - 11/2014
3	GoldIBA 01/2022 - 07/2018
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2012
3	Trastuzumab (Herceptin)FDA Link 08/2017 - 01/2013
3	EpitopesIBA 01/2013 - 02/2007
3	Interleukin-12 (IL 12)IBA 06/2006 - 02/2002
2	RutheniumIBA 01/2021 - 01/2016
2	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 07/2018
2	Tetrahydrofolate Dehydrogenase (Dihydrofolate Reductase)IBA 11/2020 - 08/2014
2	human ERBB2 proteinIBA 11/2020 - 04/2019
2	Phenobarbital (Luminal)FDA Link 01/2020 - 01/2017
2	phosphine (phosphane)IBA 01/2020 - 07/2018
2	ErbB Receptors (EGF Receptor)IBA 12/2019 - 02/2007
2	ResveratrolIBA 01/2018 - 01/2017
2	GTP Phosphohydrolases (GTPases)IBA 01/2018 - 01/2017
2	Oncogene Proteins (Oncogene Protein)IBA 08/2017 - 04/2011
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2016 - 04/2010
2	Immunoglobulin G (IgG)IBA 01/2016 - 05/2003
2	PerforinIBA 06/2014 - 04/2003
2	Cancer VaccinesIBA 01/2013 - 01/2010
1	Gold CompoundsIBA 01/2022
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	Lipid NanoparticlesIBA 08/2021
1	imidazolium- bis(imidazole)dimethylsulfoxideimidazotetrachlororuthenate(III) (NAMI-A)IBA 01/2021
1	Programmed Cell Death 1 ReceptorIBA 01/2021
1	B7-H1 AntigenIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Caspase 3 (Caspase-3)IBA 11/2020
1	NaphthoquinonesIBA 11/2020
1	acetylshikoninIBA 11/2020
1	AzolesIBA 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	Epidermal Growth Factor (EGF)IBA 01/2020
1	LigandsIBA 01/2020
1	NucleolinIBA 12/2019
1	Glu Transfer RNAIBA 12/2019
1	Messenger RNA (mRNA)IBA 12/2019
1	Phosphotransferases (Kinase)IBA 04/2019
1	Insulin-Like PeptidesIBA 04/2019
1	tyrosine receptor (receptor, tyrosine)IBA 04/2019
1	StathminIBA 01/2019
1	Proteasome Endopeptidase Complex (Proteasome)IBA 07/2018
1	Deubiquitinating EnzymesIBA 07/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2017
1	Phytoestrogens (Phytoestrogen)IBA 01/2017
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2017
1	CarcinogensIBA 01/2017
1	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 01/2017
1	Drinking WaterIBA 01/2017
1	Proteasome InhibitorsIBA 01/2017
1	saracatinibIBA 10/2016
1	Lapatinib (GW572016)FDA Link 10/2016
1	dacomitinibIBA 10/2016
1	Organometallic CompoundsIBA 01/2016
1	Liposomes (Liposome)IBA 01/2016
1	liposomal amphotericin B FDA Link 01/2016
1	Sodium Dodecyl Sulfate (Sodium Lauryl Sulfate)IBA 01/2016
1	Blood Proteins (Serum Proteins)IBA 01/2016
1	AutoantibodiesIBA 01/2016
1	PlatinumIBA 01/2016
1	4-cymene (p-cymene)IBA 01/2016
1	Immunoglobulin A (IgA)IBA 01/2016
1	PolyphenolsIBA 01/2016
1	Ruthenium CompoundsIBA 01/2016
1	Protein CoronaIBA 01/2016
1	polyacrylamideIBA 01/2016
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2016
1	SirtuinsIBA 11/2015
1	Glucose (Dextrose)FDA LinkGeneric 11/2015
1	sanguinarineIBA 08/2014
1	InterleukinsIBA 06/2014
1	dorsomorphinIBA 02/2014
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 02/2014
1	ElementsIBA 10/2012

Therapy/Procedure

11	Therapeutics 01/2022 - 10/2009
3	Immunotherapy 08/2021 - 01/2013
2	Neoadjuvant Therapy 11/2010 - 03/2005
1	Radiotherapy 01/2021
1	Drug Therapy (Chemotherapy) 01/2021
1	Oral Administration 08/2014